期刊文献+

RP-HPLC法测定洛匹那韦及其有关物质的含量 被引量:3

RP-HPLC Determination of the Content of Lopinavir and Its Related Substances
下载PDF
导出
摘要 目的:建立反相高效液相色谱法测定洛匹那韦含量及其有关物质的方法。方法:采用 Alltech Allitma C\-\{18\}柱(150mm×4.6 mm,5μm),以乙腈-20 mmol·L^(-1)磷酸二氢钾溶液(pH 6.0)(58:42)为流动相,流速1.0mL·min\+\{-1\},检测波长210nm。结果:杂质及降解产物能与洛匹那韦基线分离;在19.92~159.36μg·mL^(-1)的浓度范围内与峰面积呈良好线性关系,r=0.9999(n=7);最低检测限为0.48 ng;日内 RSD 为0.29%(n=6);日间 RSD 为0.39%(n=6)。结论:本法准确、简便,适用于洛匹那韦及其有关物质的含量测定。 Objective: To establish an RP - HPLC method for determination of lopinavir and its related substances. Method :The sample was separated by Alhech Allitma C18 (150 mm ×4. 6 mm,5μm)column with acetonitrile- 20 mmol· L^-1 monopotassium phosphate( adjusted to pH 6. 0)(58:42)as mobile phase,The flow rate was 1.0 mL · min^-1 and the detection wavelength was at 210 nm. Results:Its related substances could be separated from lopinavir. The linear range of lopinavir was 19. 92 - 159.36μg · mL^-1 , r = 0. 9999 (n = 7). The low detected limit was 0. 48 ng. The RSD of intra - day was 0. 29% (n =6)and inter - day was 0. 39% (n =6). Conclusion: This method is simple, accurate and suitable for the determination of lopinavir and its related substances.
作者 杨伟峰
出处 《药物分析杂志》 CAS CSCD 北大核心 2005年第8期940-942,共3页 Chinese Journal of Pharmaceutical Analysis
  • 相关文献

参考文献3

  • 1John Ray, Simultaneous determination of indinavir, ritonavir and lopinavir( ABT 378 ) in human plasma by high - performance liquid chromatography. J Chromatogr B,2002,775:225.
  • 2U S Justesen. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir,nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography. J Chromatogr B ,2003,783:491.
  • 3Eric J Stoner. Synthesis of HIV protease inhibitor ABT - 378 ( lopinavir). Org Process Res Dev,2000,4:264.

同被引文献2134

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部